Research Assistant

Human immunology research in world leading environment

3-year contract with prospect of renewal

Attractive salary packaging & superannuation options

About QIMR Berghofer:

QIMR Berghofer is a world-leading translational medical research institute focused on improving health by developing new diagnostics, better treatments and prevention strategies, specifically in the areas of cancer, infectious diseases, mental health and chronic disorders. Based in Herston, Brisbane and working in close collaboration with clinicians and other research institutes, QIMR Berghofer is home to more than 600 scientists, students and support staff.

About the Human Malaria Immunology Laboratory:

Our group aims to understand the development of protective immunity to malaria in humans in order to inform vaccine development. We use cutting edge technologies and in vitro systems to human samples from experimental and natural infection cohorts.

Role Purpose / Responsibilities :

Reporting to Team Head and EMBL Australia Group Leader Dr Boyle, you will perform and analyse experiments, provide technical support to group and assist with laboratory management. This position is an exciting opportunity to work in translational human research and develop skills in cutting edge immunological techniques.

About you:

This role will suit individuals with laboratory experience, outstanding technical capabilities and ability to learn. You will have excellent attention to detail and record keeping and time management skills. Experience in one or more of the following techniques/skills is highly desirable; Plasmodium in vitro culture, multi-parametric flow-cytometry, CyTOF, R analytic platforms, handling human sample.

What we offer:

Salary Packaging

Bonus Superannuation

State of the art facilities

Stimulating work setting focussed on cutting edge medical research

Supportive/collaborative team environment

Salary:

Salary range is $60,712 to $82,202 per annum and is commensurate with experience. This is a full time appointment for 3 years with the prospect of renewal.